Browse published site content mentioning or authored by this company. Sorted by original publication date; undated items appear last.
← Back to company profileShowing 1–12 / 26 related items
Explore how PK–PD biomarkers, exposure–response modeling and fit-for-purpose bioanalysis support clinical dose optimization and FDA Project Optimus
Learn how to evaluate a CRO for ADC bioanalysis: three-analyte PK coverage, subclass-specific total antibody methods, and hybrid LC-MS/MS workflows.
Discover how integrated bioanalysis, biomarkers, ADA assessment and Pop PK/PD modeling support Model-Informed Drug Development and biologic dose selection.
Learn the six critical quality attributes (CQAs) every ADC program should monitor and how analytical characterization supports successful CMC development.
Explore key strategies for ADC bioanalysis, including DAR characterization, payload stability, and LC-MS-based biotransformation studies.
Discover how high-resolution mass spectrometry enhances biologics characterization, supporting critical analyses from peptide mapping to impurity profiling
Fc glycosylation controls antibody efficacy and safety. Learn what FDA expects for characterization, manufacturing and biosimilar comparability.
What does the FDA require to approve a monoclonal antibody biosimilar in 2026? Analytical, PK, clinical, and immunogenicity evidence explained.
Learn the six most common analytical gaps in biosimilar development, why regulators flag them, and how to fix them early to reduce regulatory risk.
WCBP 2026 highlights why comparability is now the key late-stage challenge, from analytical CQA assessment to regulatory expectations and CMC strategy.
Sterility and endotoxin testing define release safety in biologics, ensuring microbial control, regulatory compliance, and patient protection.
Overview of D0 species in ADCs, compete for target binding, reduce ADC potency, and how they are characterized analytically in development.
Name matches are discovery leads; verify entity identity and transaction roles in the original source. Same-field reading is kept separate.